China
Africa
Explore chapters and articles related to this topic
The Practice Team
Published in James Sherifi, General Practice Under the NHS, 2023
The pharmacy technician worked under the direction of the pharmacist in dispensing drugs, reviewing repeat prescriptions, stock management, storage of drugs and vaccines, sales of over-the-counter medication, and responding to patient queries.
Pharmacy Supportive Personnel
Published in William N. Kelly, Pharmacy, 2018
A pharmacy technician is an individual working in a pharmacy who, under the direct supervision of a licensed pharmacist, aids in the highest-level pharmacy tasks that do not require the professional judgment of the pharmacist. Pharmacy technicians may assist in routine activities in the pharmacy, such as unpacking goods, stocking shelves, and delivering medications, however these may also be carried out by other pharmacy extenders.
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects
Published in Expert Review of Molecular Diagnostics, 2022
Michael Klepser, Renee R. Koski
The SARS-CoV-2 pandemic has strained all aspects of healthcare, and pharmacy is no exception. The idea of adding more work on an already overburdened staff cannot be done without due diligence and an assessment of the benefits to patients and staff versus the possible burdens. A number of studies have been published that examine the workflow and financial impact of POCT services in the community pharmacy [15,28,29]. Regardless of the test performed, it was noted that the amount of hands-on time spent by pharmacy staff was typically less than 10 minutes. This time included that needed to interact with patients to deem eligibility for testing services, conduct intake interviews and collect vital signs, prepare and run tests, and convey test results. Although time was constant, use of a pharmacy technician to the full extent allowed by their scope of practice generally resulted in pharmacists spending less than five minutes out of their dispensing functions and minimizing personnel expenses. Therefore, it appears that POCT services can be efficiently incorporated into pharmacy workflow in a manner that is minimally disruptive to other functions. This process can be further improved if patient encounters are scheduled so staffing can be adjusted appropriately.
CPD preferences and activities of general practitioners, registered pharmacy staff and general practice nurses in NHS Scotland – a questionnaire survey
Published in Education for Primary Care, 2019
David E. Cunningham, Anna Alexander, Sarah Luty, Leon Zlotos
Preferences for days and time of the week differed for each profession (Figure 5). All professions preferred weekdays to weekends, and Friday evening was the least popular time during weekdays. GPNs and pharmacy technicians preferred weekday-daytime education than evenings or weekends. Approximately a third of GPs would undertake CPD during Saturday daytime. There was no difference in preference for day of the week between R&R practitioners and non-R&R practitioners, except for the four least popular time slots where R&R practitioners appeared to be more accepting of these (Friday evening 19.8% vs 15.1%,CHI = 4.989 p < 0.05, Saturday evening 7.5% vs 3.3%, CHI = 14.468 p < 0.01, Sunday daytime 23.7% vs 17.0%, CHI = 9.479 p < 0.05, Sunday evening 8.6% vs 3.8%, CHI = 17.213 p < 0.01).
The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma
Published in Oncology Issues, 2021
Robert A. Figlin, Jocelyn Mohs, Laura S. Wood
Dr. Mohs. Having a vigorous prior authorization process on the front end of starting immunotherapy treatment can prevent many reimbursement issues. Staff dedicated to completing all pre‐certifications or prior authorizations can be very efficient, especially if they have a background in coding and reimbursement. Pharmacists or even experienced pharmacy technicians can help lead the prior authorization process, as well as assist with submitting denial appeals on behalf of providers. One challenge in the realm of prior authorization and reimbursement is the lag in payer coverage for immunotherapy agents with new data showing positive outcomes in a unique treatment setting.